Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

The clinical trial showed this experimental medication to be much more effective than any existing GLP-1 drug. But that much ...

This study protocol outlines a 12-week randomized trial testing whether a MIND diet intervention is feasible, acceptable, and ...

Scientists found that certain molecules made by gut bacteria travel to the liver and help control how the body uses energy.

Eli Lilly's next-gen obesity drug delivered major weight loss in a trial, but some patients stopped using it after losing too ...

Lilly’s closely watched retatrutide spurred as much as 29% weight loss in a Phase 3 study, a finding that is “raising the bar ...

Eli Lilly said its next generation weight-loss drug retatrutide resulted in significant weight loss and reduced knee pain in ...

The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

A study by researchers at the Federal University of São Carlos (UFSCar) in Brazil, in partnership with University College ...

Soybean oil, used for cooking in more than half of American households, is linked to a higher risk of obesity in a new study.

Visceral obesity is associated with increased left ventricular mass and reduced ventricular volumes — suggesting concentric ...

Obesity accelerates the rise of Alzheimer’s-related blood biomarkers far more rapidly than previously recognized. Long-term imaging and plasma data show that obese individuals experience much faster ...